TIFFANY COCHRAN: Open Payments
NPI 1104358514 · OKATIE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 8 payments from 6 companies in 2025. Trend: 2023 $98 · 2024 $200 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $139 |
| Gilead Sciences, Inc. | 1 | $124 |
| Amgen Inc. | 2 | $32 |
| Theratechnologies Inc. | 1 | $27 |
| Corcept Therapeutics | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: Wegovy, Biktarvy, EGRIFTA, Korlym, Symbravo, REPATHA, KRYSTEXXA, Rybelsus.
Industry payments across SC — which companies pay providers there.
